LGALS3 encodes a member of the galectin family of carbohydrate binding proteins. Members of this protein family have an affinity for beta-galactosides. lectin, galactoside binding soluble 3 is characterized by an N-terminal proline-rich tandem repeat domain and a single C-terminal carbohydrate recognition domain. lectin, galactoside binding soluble 3 can self-associate through the N-terminal domain allowing it to bind to multivalent saccharide ligands. lectin, galactoside binding soluble 3 localizes to the extracellular matrix, the cytoplasm and the nucleus. lectin, galactoside binding soluble 3 plays a role in numerous cellular functions including apoptosis, innate immunity, cell adhesion and T-cell regulation. lectin, galactoside binding soluble 3 exhibits antimicrobial activity against bacteria and fungi. Alternate splicing results in multiple transcript variants

CBP 35 Polyclonal Antibody detects endogenous levels of CBP 35 protein.

Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB: 1:500-1:2000, IHC-p: 1:100-1:300, IF: 1:200-1:1000, ELISA: 1:20000. Not yet tested in other applications.

CBP 35 Polyclonal Antibody product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Find more details at http://www.abbkine.com/product/cbp-35-polyclonal-antibody-abp50882.

Abbkine Scientific Co., Ltd. was founded by a number of scientists and marketing experts in the field of life science in California in 2012. With growing demands from Asia Pacific, it move its headquarters to China. Combining cutting edge technology from United States with China's manufacturing engineering and cost advantages, we aim to provide innovative, high quality assay kits, recombinant proteins, antibodies and other research tools to accelerate life science fundamental research, drug discovery, etc.